Amondina, Sheryl .
HRN: 09-16-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2025
AMPICILLIN 1GM (VIAL)
03/31/2025
04/07/2025
IV
2g
Q6hrs
PROM - Thinly
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes